Chemokine Receptor D6 Polyclonal Antibody

CCBP2 encodes a beta chemokine receptor, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. Chemokines and their receptor-mediated signal transduction are critical for the recruitment of effector immune cells to the inflammation site. CCBP2 is expressed in a range of tissues and hemopoietic cells. The expression of this receptor in lymphatic endothelial cells and overexpression in vascular tumors suggested its function in chemokine-driven recirculation of leukocytes and possible chemokine effects on the development and growth of vascular tumors. This receptor appears to bind the majority of beta-chemokine family members; however, its specific function remains unknown. CCBP2 is mapped to chromosome 3p21.3, a region that includes a cluster of chemokine receptor genes.

The CHST2 Polyclonal Antibody is a highly specific and sensitive antibody designed for use in various research applications. This antibody is produced using high-quality polyclonal antibodies that have been purified and validated to ensure optimal performance and reproducibility. The CHST2 Polyclonal Antibody is specifically designed to target CHST2, a sulfotransferase enzyme that is involved in the biosynthesis of chondroitin sulfate proteoglycans. This antibody is suitable for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. The CHST2 Polyclonal Antibody is a reliable and effective tool for researchers studying the role of CHST2 in various biological processes. With its high specificity and sensitivity, this antibody is an essential tool for any researcher working in the field of molecular biology.